Dr. med. Anne Thews joins Elastrin Therapeutics as CMO

We are happy to announce that Dr. med. Anne Thews has joined the company and is appointed to our Chief Medical Officer.

Dr. med Anne Thews is Elastrin's new CMO.

Anne has achieved an impressive track record during the past 20 years both in strategic and tactical clinical, as well life-science oriented marketing: Anne’s proven significant expertise spans from product design, product launch and product life cycle management to developing and implementing business plans, go-to-market strategies and market access programs in existing and newly established companies. She has also demonstrated a strong medical affairs know-how by driving clinical development strategies, conducting > 30 clinical trials and building global networks of medical institutions, clinical societies, IVD and pharmaceutical companies, NPOs, industrial organizations, consulting companies, investors and distributors.

Her combined professional experience in marketing, sales and medical affairs, her in-depth understanding of the global life-science market and as a trained medical doctor make her a valuable asset to Elastrin Therapeutics.

Legal NoticePrivacy Policy | Contact Us

© 2017-2021 Elastrin Therapeutics Inc.